Rubino F, Cummings DE, Eckel RH, Cohen RV, Wilding JPH, Brown WA, et al. Definition and diagnostic criteria of clinical obesity. Lancet Diabetes Endocrinol. 2025;13:221–62. https://doi.org/10.1016/S2213-8587(24)00316-4.
Article PubMed PubMed Central Google Scholar
Klöting N, Blüher M. Adipocyte dysfunction, inflammation and metabolic syndrome. Rev Endocr Metab Disord. 2014;15:277–87. https://doi.org/10.1007/s11154-014-9301-0.
Article CAS PubMed Google Scholar
Rogero MM, Calder PC. Obesity, inflammation, toll-like receptor 4 and fatty acids. Nutrients. 2018;10:1–19. https://doi.org/10.3390/nu10040432.
WHO. WHO | Obesity and overweight [Internet]. Obesity and overweight. World Health Organization; 2024 [cited 2025 May 5]. https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight. Accessed 5 May 2025.
Zhang X, Ha S, Lau HCH, Yu J. Excess body weight: Novel insights into its roles in obesity comorbidities. 2023.
WOF. World Obesity Atlas 2024 [Internet]. London; 2024. https://s3-eu-west-1.amazonaws.com/wof-files/WOF_Obesity_Atlas_2024.pdf
Afshin A, Sur PJ, Fay KA, Cornaby L, Ferrara G, Salama JS, et al. Health effects of dietary risks in 195 countries, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2019;393:1958–72. https://doi.org/10.1016/S0140-6736(19)30041-8.
Lu W, Ou T, Song Q. others. Ultra-Processed Food Consumption Is Associated with an Increased Risk of Abdominal Obesity. 2025; https://doi.org/10.3390/foods14223955
Ferreira-Hermosillo A, Ibanez RM, Perez-Dionisio EK, Villalobos-Mata KA. Obesity as a neuroendocrine disorder. Arch Med Res. 2023. https://doi.org/10.1016/j.arcmed.2023.102896.
Yi C-X, Tschöp MH. Brain–gut–adipose-tissue communication pathways at a glance. Dis Model Mech. 2012;5:583–7. https://doi.org/10.1242/dmm.009902.
Article CAS PubMed PubMed Central Google Scholar
Schéle E, Grahnemo L, Anesten F, Hallén A, Bäckhed F, Jansson J-O. The gut microbiota reduces leptin sensitivity and the expression of the obesity-suppressing neuropeptides Proglucagon (Gcg) and Brain-Derived Neurotrophic Factor (Bdnf) in the central nervous system. Endocrinology. 2013;154:3643–51. https://doi.org/10.1210/en.2012-2151.
Article CAS PubMed Google Scholar
Kase BE, Liese AD, Zhang J, Murphy EA, Zhao L, Steck SE. The development and evaluation of a literature-based dietary index for gut microbiota. Nutrients. 2024. https://doi.org/10.3390/nu16071045.
Article PubMed PubMed Central Google Scholar
Carrera-Bastos P, Fontes, O’Keefe. Lindeberg, Cordain. The western diet and lifestyle and diseases of civilization. Res Rep Clin Cardiol. 2011;15. https://doi.org/10.2147/RRCC.S16919.
Franks PW, Hindawi Limited. The complex interplay of genetic and lifestyle risk factors in type 2 diabetes: an overview. Scientifica (Cairo). 2012;2012:1–11. https://doi.org/10.6064/2012/482186.
Fisberg M, Maximino P, Kain J, Kovalskys I, Elsevier Editora Ltda. Obesogenic environment – intervention opportunities. J Pediatr (Rio J). 2016. https://doi.org/10.1016/j.jped.2016.02.007.
Malesza IJ, Malesza M, Walkowiak J. others. High-Fat, Western-Style Diet, Systemic Inflammation, and Gut Microbiota. 2021; https://doi.org/10.3390/cells10113164
Qin Q, Yan S, Yang Y, Chen J, Li T, Gao X, et al. A metagenome-wide association study of the gut microbiome and metabolic syndrome. Front Microbiol. 2021. https://doi.org/10.3389/fmicb.2021.682721.
Article PubMed PubMed Central Google Scholar
Zheng Y, Li T, Cui H, Song J. Dietary index for gut microbiota, metabolic syndrome, and long-term mortality: National Health and Nutrition Examination Survey, 2007–2018. Diabetol Metab Syndr. 2025;17:191. https://doi.org/10.1186/s13098-025-01761-1.
Article PubMed PubMed Central Google Scholar
Chanda D, De D. Meta-analysis reveals obesity associated gut microbial alteration patterns and reproducible contributors of functional shift. Gut Microbes. 2024. https://doi.org/10.1080/19490976.2024.2304900.
Article PubMed PubMed Central Google Scholar
Valles-Colomer M, Blanco-Míguez A, Manghi P, Asnicar F, Dubois L, Golzato D, et al. The person-to-person transmission landscape of the gut and oral microbiomes. Nature. 2023;614(7946):125–35. https://doi.org/10.1038/s41586-022-05620-1.
Article CAS PubMed PubMed Central Google Scholar
Liu R, Hong J, Xu X, Feng Q, Zhang D, Gu Y, et al. Gut microbiome and serum metabolome alterations in obesity and after weight-loss intervention. Nat Med. 2017;23(7):859–68. https://doi.org/10.1038/nm.4358.
Article CAS PubMed Google Scholar
Xu Z, Jiang W, Huang W, Lin Y, Chan FKL, Ng SC. Gut microbiota in patients with obesity and metabolic disorders — a systematic review. Genes & Nutrition. 2021;17(1):2. https://doi.org/10.1186/s12263-021-00703-6.
Cummings JH. Short chain fatty acids in the human colon. Gut. 1981;22:763–79. https://doi.org/10.1136/gut.22.9.763.
Article CAS PubMed PubMed Central Google Scholar
Cronin P, Joyce SA, O’Toole PW, O’Connor EM. Dietary fibre modulates the gut microbiota. Nutrients. 2021;13:1655. https://doi.org/10.3390/nu13051655.
Article CAS PubMed PubMed Central Google Scholar
Liu E, Ji X, Zhou K. Akkermansia muciniphila for the prevention of type 2 diabetes and obesity: a meta-analysis of animal studies. Nutrients. 2024;16:3440. https://doi.org/10.3390/nu16203440.
Article CAS PubMed PubMed Central Google Scholar
Giannoudaki E, Hernandez-Santana YE. others. Interleukin-36 cytokines alter the intestinal microbiome and can protect against obesity and metabolic dysfunction. 2019; https://doi.org/10.1038/s41467-019-12038-1
Belenguer A, Duncan SH, Calder AG, Holtrop G, Louis P, Lobley GE, et al. Two routes of metabolic cross-feeding between Bifidobacterium adolescentis and butyrate-producing anaerobes from the human gut. Appl Environ Microbiol. 2006;72:3593–9. https://doi.org/10.1128/AEM.72.5.3593-3599.2006.
Article CAS PubMed PubMed Central Google Scholar
Flint HJ, Scott KP, Duncan SH, Louis P, Forano E. Microbial degradation of complex carbohydrates in the gut. Gut Microbes. 2012;3:289–306. https://doi.org/10.4161/gmic.19897.
Article PubMed PubMed Central Google Scholar
Kelly CJ, Zheng L, Campbell EL, Saeedi B, Scholz CC, Bayless AJ, et al. Crosstalk between microbiota-derived short-chain fatty acids and intestinal epithelial HIF augments tissue barrier function. Cell Host Microbe. 2015;17:662–71. https://doi.org/10.1016/j.chom.2015.03.005.
Article CAS PubMed PubMed Central Google Scholar
Chambers ES, Viardot A, Psichas A, Morrison DJ, Murphy KG, Zac-Varghese SEK, et al. Effects of targeted delivery of propionate to the human colon on appetite regulation, body weight maintenance and adiposity in overweight adults. Gut. 2015;64:1744–54. https://doi.org/10.1136/gutjnl-2014-307913.
Article CAS PubMed Google Scholar
Brown AJ, Goldsworthy SM, Barnes AA, Eilert MM, Tcheang L, Daniels D, et al. The orphan G protein-coupled receptors GPR41 and GPR43 are activated by propionate and other short chain carboxylic acids. J Biol Chem. 2003;278:11312–9. https://doi.org/10.1074/jbc.M211609200.
Article CAS PubMed Google Scholar
Rosendo-Silva D, Viana S, Carvalho E, Reis F, Matafome P. Are gut dysbiosis, barrier disruption, and endotoxemia related to adipose tissue dysfunction in metabolic disorders? Overview of the mechanisms involved. Int Emerg Med. 2023. https://doi.org/10.1007/s11739-023-03262-3.
Jiang Z, He L, Li D, Zhuo L, Chen L, Shi RQ, et al. Human gut microbial aromatic amino acid and related metabolites prevent obesity through intestinal immune control. Nat Metab. 2025;7(4):808–22. https://doi.org/10.1038/s42255-025-01246-5.
Article CAS PubMed PubMed Central Google Scholar
Wang K, Liao M, Zhou N, Bao L, Ma K, Zheng Z, et al. Parabacteroides distasonis Alleviates Obesity and Metabolic Dysfunctions via Production of Succinate and Secondary Bile Acids. Cell Rep. 2019;26:222-235.e5. https://doi.org/10.1016/j.celrep.2018.12.028.
Comments (0)